TABLE OF CONTENTS
CHAPTER 1 INTRODUCTION
1.1 KEY TAKES AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 METHODOLOGY
CHAPTER 2 UNDERSTANDING OF THE MARKET
2.1 KEY ELEMENTS OF THE MARKET
CHAPTER 3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 ADVANCEMENT IN TECHNOLOGY
3.1.2 HABITS INFLUENCING THE CORONARY STENT MARKETS
3.1.2.1 Smoking
3.1.2.2 Poor Diet and Obesity
3.1.2.3 Physical Inactivity
3.1.2.4 Alcohol Intake
3.1.3 AGING POPULATION - TRIGGER FOR CORONARY STENT MARKETS
3.1.4 RESTENOSIS – FUELLING CORONARY STENT MARKET
3.2 CHALLENGES
3.3 OPPORTUNITIES
3.4 KEY TRENDS
CHAPTER 4 MARKET SEGMENTATION
4.1 BY PRODUCT
4.1.1 DRUG ELUTING STENT
4.1.1.1 Market Metrics
4.1.1.1.1 Drivers
4.1.1.1.2 Restraints
4.1.1.1.2.1 Allergic Reactions
4.1.1.1.2.2 Long Term Antiplatelet Therapy:
4.1.1.1.3 Opportunities
4.1.1.2 Market Size & Growth Rate
4.1.1.3 Major Players
4.1.2 BARE-METAL STENT, STAINLESS STEEL
4.1.2.1 Market Metrics
4.1.2.1.1 Drivers
4.1.2.1.2 Restraints
4.1.2.1.2.1 Potential Side Effects of Stents
4.1.2.1.3 Opportunity
4.1.2.2 Market Size & Growth Rates
4.1.2.3 Major Players
4.1.3 ABSORBABLE STENTS
4.1.3.1 Market Metrics
4.1.3.1.1 Drivers
4.1.3.1.2 Challenges
4.1.3.1.3 Opportunities
4.1.4 BIOACTIVE STENT
4.1.4.1 Market Metrics
4.1.4.1.1 Drivers
4.2 BY GEOGRAPHY
4.2.1 NORTH AMERICA MARKET
4.2.1.1 Market Metrics
4.2.1.1.1 Drivers
4.2.1.1.2 Challenges
4.2.1.1.3 Opportunities
4.2.1.2 Market Size & Growth Rates
4.2.2 EUROPEAN MARKET
4.2.2.1 Market Metrics
4.2.2.1.1 Drivers
4.2.2.1.2 Challenges
4.2.2.1.3 Opportunities
4.2.2.2 Market Size & Growth Rates
4.2.2.3 Major Players
4.2.3 ASIA-PACIFIC MARKET
4.2.3.1 Market Metrics
4.2.3.1.1 Drivers
4.2.3.1.2 Challenges
4.2.3.2 Market Size & Growth Rates
4.2.3.3 Competition Analysis
CHAPTER 5 COMPETITIVE LANDSCAPE
CHAPTER 6 TREND ANALYSIS
6.1 TECHNOLOGY-STRATEGY MAPPING
6.2 INTRODUCTION OF NEWER STENT AND INCREASE IN NUMBER OF PARTICIPANTS: A TREND
6.3 CASE STUDY
6.3.1 LIFE FOR INNOVATION, LIFE FOR THE BUSINES
CHAPTER 7 CLINICAL TRIALS
7.1 CLINICAL TRIALS: US
7.2 CLINICAL TRIALS: JAPAN
7.3 CLINICAL TRIALS: CHINA
7.4 CLINICAL TRIALS: INDIA
7.5 CLINICAL TRIALS: GERMANY
7.6 CLINICAL TRIALS: FRANCE
7.7 CLINICAL TRIALS: UNITED KINGDOM
CHAPTER 8 COMPANY PROFILES
8.1 BOSTON SCIENTIFIC
8.1.1 OVERVIEW
8.1.2 REVENUE DISTRIBUTION OF BOSTON SCIENTIFIC BY GEOGRAPHY
8.1.3 KEY PRODUCTS
8.1.3.1 Cardiac rhythm management (CRM) products
8.1.3.2 Cardiovascular products
8.1.3.3 Coronary revascularization products
8.1.3.4 Electrophysiology products
8.1.3.5 Endoscopy products & Gastroenterology products
8.1.3.6 Urology/Women's health products
8.1.3.7 Neuro-modulation products
8.2 JOHNSON & JOHNSON
8.2.1 OVERVIEW
8.2.2 JNJ’S BUSINESS SEGMENTATION
8.2.3 JNJ’S REVENUE BY GEOGRAPHIC
8.2.4 KEY PRODUCTS SEGMENTS
8.3 ABBOTT LABORATORIES
8.3.1 OVERVIEW
8.3.2 BUSINESS SEGMENTS
8.3.3 DEVELOPMENTS
8.3.4 REVENUE DISTRIBUTIONS
8.3.5 PRODUCT PROFILE
8.4 MEDTRONIC, INC.
8.4.1 OVERVIEW
8.4.2 SEGMENTS
8.4.2.1 Medtronic’s Product wise Segmentation
8.4.2.2 Market Share by Geography
8.4.3 PRODUCT PROFILE
8.5 BETRIEBSKRANKENKASSE DER B. BRAUN MELSUNGEN
8.5.1 OVERVIEW
8.5.2 BUSINESS SEGMENTATION
8.5.3 PRODUCT PROFILE
8.6 BIORING SA
8.6.1 OVERVIEW
8.6.2 BUSINESS SEGMENTS
8.6.3 PRODUCT PROFILE
8.7 CORNOVA
8.7.1 OVERVIEW
8.7.2 PRODUCT PROFILE
8.8 BALTON LTD.
8.8.1 OVERVIEW
8.8.2 PRODUCT PROFILE